Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Martti Kulvik"'
Autor:
Janni Kunttu, Venla Wallius, Martti Kulvik, Pekka Leskinen, Jussi Lintunen, Timokleia Orfanidou, Diana Tuomasjukka
Publikováno v:
Sustainability; Volume 14; Issue 16; Pages: 9999
Global trends influence the approaches and mindset for using natural resources and technological capacities. Participatory scenario methods have proven useful in long-term foresight. However, country-level foresight studies often ignore the broader t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83ac3d070a738b3265e64269874997f1
Publikováno v:
Digital Work and the Platform Economy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2f87ee48647de3a536d7232895d9fe6
https://doi.org/10.4324/9780429467929-7
https://doi.org/10.4324/9780429467929-7
Autor:
Wihuri, Eero (AUTHOR)
Publikováno v:
Kiinteistö ja Energia. 2022, Issue 8, p6-9. 4p. 3 Color Photographs.
Autor:
Leena Kankaanranta, Iiro Auterinen, Heikki Joensuu, Hanna Koivunoro, Sauli Savolainen, Martti Kulvik, Tiina Seppälä, Eero Hippeläinen, Juha Laakso
Publikováno v:
Koivunoro, H, Hippeläinen, E, Auterinen, I, Kankaanranta, L, Kulvik, M, Laakso, J, Seppälä, T, Savolainen, S & Joensuu, H 2015, ' Biokinetic analysis of tissue boron (10B) concentrations of glioma patients treated with BNCT in Finland ', Applied Radiation and Isotopes, vol. 106, pp. 189-194 . https://doi.org/10.1016/j.apradiso.2015.08.014
Europe PubMed Central
Europe PubMed Central
A total of 98 patients with glioma were treated with BPA-F-mediated boron neutron capture therapy (BNCT) in Finland from 1999 to 2011. Thirty-nine (40%) had undergone surgery for newly diagnosed glioblastoma and 59 (60%) had malignant glioma recurren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dac33a2d33ce8f1dda35b8b1bad4925
https://doi.org/10.1016/j.apradiso.2015.08.014
https://doi.org/10.1016/j.apradiso.2015.08.014
Autor:
Juha E. Jääskeläinen, Matti Seppälä, Martti Kulvik, Raine Hermans, Merja Rasilainen, Anders Paetau, Eija Järviluoma, Juha Laakso, Jyrki Vähätalo, Merja Kallio, Inkeri Ruokonen
Publikováno v:
APPLIED RADIATION AND ISOTOPES. 106:207-212
We studied the uptake of boron after 100 mg/kg BPA infusion in three meningioma and five schwannoma patients as a pre-BNCT feasibility study. With average tumour-to-whole blood boron concentrations of 2.5, we discuss why BNCT could, and probably shou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::879af940fd7cd449e5bef34d7429edeb
http://juuli.fi/Record/0274709815
http://juuli.fi/Record/0274709815
Publikováno v:
International Journal of Innovation and Technology Management. :279-301
In this paper our aim is to assess the potential of using patent statistics in predicting the future sales anticipations and present value of a company active in the science-based industry. Instead of using conventional patent and patent application
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1cb084c83aa487b3eda60c644f70d38
https://doi.org/10.1142/s0219877008001436
https://doi.org/10.1142/s0219877008001436
Publikováno v:
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 106
We have constructed a formal model on cost-benefit of new technology in health care, and apply it on boron neutron capture therapy (BNCT). We assume that the patient health benefit from getting cured in acute treatment is always higher than the patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64cdc6c1046a20e2aa8123169f9aec71
https://pubmed.ncbi.nlm.nih.gov/26365901
https://pubmed.ncbi.nlm.nih.gov/26365901
Autor:
Vesa Oikonen, Olli Eskola, Juha E. Jääskeläinen, Martti Kulvik, Kaisa Lehtiö, Katja Havu-Aurén, Johanna Kiiski, Jyrki Vähätalo, Heikki Minn, Ville Vuorinen
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 34:87-94
Meningiomas and schwannomas associated with neurofibromatosis 2 (NF2) are difficult to control by microsurgery and stereotactic radiotherapy alone. Boron neutron capture therapy (BNCT) is a chemically targeted form of radiotherapy requiring increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9a12856c0767431704588e8a69cbba3
https://doi.org/10.1007/s00259-006-0154-y
https://doi.org/10.1007/s00259-006-0154-y
Autor:
Marjatta Snellman, Juha Laakso, Markus Färkkilä, Merja Rasilainen, Martti Kulvik, Merja Kallio, Eija Järviluoma, Raine Hermans, Jyrki Vähätalo, Judit Benczik
Publikováno v:
Applied Radiation and Isotopes. 61:975-979
Boron biodistribution after intravenous infusion of 4-dihydroxyborylphenylalanine-fructose (BPA-F) complex was investigated in six dogs. Blood samples were evaluated during and following doses of 205 and 250 mg/kgbw BPA in a 30 min infusion, and 500
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::261066503cb97e04a668a42b3c00eb71
https://doi.org/10.1016/j.apradiso.2004.05.022
https://doi.org/10.1016/j.apradiso.2004.05.022
Autor:
Markus Färkkilä, Martti Kulvik, Johanna Karila, Mikko Tenhunen, Iiro Auterinen, Sauli Savolainen, Juha Jääskeläinen, Juha Laakso, Inkeri Ruokonen, Mika Kortesniemi, Anders Paetau, Heikki Minn, Leena Kankaanranta, Merja Kallio, Petri Kotiluoto, Tom Serén, Päiivi Ryynänen, Eija Järviluoma, Antti Brander, Tiina Seppälä, Heikki Joensuu, Jyrki Vähätalo
Publikováno v:
University of Helsinki
Two clinical trials are currently running at the Finnish dedicated boron neutron capture therapy (BNCT) facility. Between May 1999 and December 2001, 18 patients with supratentorial glioblastoma were treated with boronophenylalanine (BPA)-based BNCT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b6bd2f0e7d3b84ebe035e2d6a0bb68e
https://doi.org/10.1007/bf02699939
https://doi.org/10.1007/bf02699939